Company / Operating Income per Share
Acadia Pharmaceuticals Operating Income per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
$0.63
FY2025
5-year range
-$1.39 / $1.40
FY2021-FY2025
Trend
-55.1%
vs FY2024
Sector context
#43 of 201
Health Care
What the data says
Acadia Pharmaceuticals's operating income per share of $0.63 is higher than 79% of companies in the Health Care sector (FY2025). Operating Income per Share has fluctuated over the past 10 years, ranging from $-2.68 in FY2016 to $1.40 in FY2024.
Based on SEC 10-K filings.
0.63 in FY2025. Top quartile in the Health Care sector.
Improved from $-0.45 to $0.63 over the past 2 years.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
+119.4% above sector average
Key checks
Key Insights
- In FY2025, operating income per share decreased 55.1% year-over-year.
- Ranks #43 out of 201 companies in the Health Care sector.
- Peak operating income per share was recorded in FY2024.
- Lowest operating income per share in the period was in FY2016.
Company context
Key Data Points
- Strong profit margin: 24.9%
- Low earnings quality (accrual-heavy earnings)
- Strong return on equity: 28.5%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.63 | -55.1% |
| FY2024 | $1.40 | +409.6% |
| FY2023 | -$0.45 | +67.4% |
| FY2022 | -$1.39 | -30.1% |
| FY2021 | -$1.07 | +42.2% |
| FY2020 | -$1.85 | -7.7% |
| FY2019 | -$1.71 | +13.8% |
| FY2018 | -$1.99 | +17.4% |
| FY2017 | -$2.41 | +10.0% |
| FY2016 | -$2.68 | -62.7% |
As of FY2025 · SEC 10-K · Updated Jul 1, 2026